6-Thioguanine in the treatment of psoriasis: A case report and literature review

Journal of Cutaneous Medicine and Surgery

Volumn 6, Issue 6, 2002, Pages 546-550

  Sherer, Daniel W ^a   Lebwohl, Mark G ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; ETRETINATE; METHOTREXATE; METHOXSALEN; RETINOID; TIOGUANINE;

AGED; ANEMIA; ARTICLE; BONE MARROW DEPRESSION; CASE REPORT; CLINICAL FEATURE; DRUG EFFICACY; DRUG MECHANISM; EPISTAXIS; GINGIVA BLEEDING; HUMAN; LEUKOPENIA; MALE; PRIORITY JOURNAL; PSORIASIS; PUSTULAR PSORIASIS; PUVA; THROMBOCYTOPENIA;

AGED; ANTIMETABOLITES, ANTINEOPLASTIC; BONE MARROW; DRUG ADMINISTRATION SCHEDULE; HUMANS; MALE; PSORIASIS; THIOGUANINE;

EID: 0036872228     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10227-001-0140-8     Document Type: Article

References (18)

1. Zackheim HS, Glogau RG, Fisher DA, et al. 6-Thioguanine treatment of psoriasis: Experience in 81 patients. J Am Acad Dermatol 1994; 30:452-458.
2. Molin L, Thomsen K. Thioguanine treatment in psoriasis. Acta Derm Venereol 1987; 67:85-88.
3. Demis DJ, Brown CS, Crosby WH. Thioguanine in the treatment of certain autoimmune, immunologic, and related diseases. Am J Med 1964; 3:195-205.
4. Zackheim HS, Maibach HI, (1985) 6-Thioguanine. In: Roenigk HI, Maibach HI eds. Psoriasis Marcel Dekker, New York.
5. Silvis NG, Levine N. Pulse dosing of thioguanine in recalcitrant psoriasis. Arch Dermatol 1999; 135:433-437.
6. Lepage GA, Whiecar JP. Pharmacology of 6-thioguanine in man. Cancer Res 1971; 31:1627-1631.
7. Zackheim HS, Maibach HI. Treatment of psoriasis with 6-thioguanine. Semin Dermatol 1985; 4:283-288.
8. Kao NL, Rosenblate HJ. 6-Thioguanine therapy for psoriasis causing toxic hepatic venoocclusive disease. J Am Acad Dermatol 1993; 28:1017-1018.
9. Bras G, Jelliffe DB, Stewart KL. Veno-occlusive disease of liver with nonportal type of cirrhosis occurring in Jamaica. Arch Pathol 1954; 57:285-300.
10. Brooks SHE, Miller CG, McKenzie K, et al. Acute venoocculsive disease of the liver: Fine structure in Jamaican children. Arch Pathol 1970; 89:507-520.
11. Griner PF, Elbadawi A, Packman CH. Veno-occlusive disease of the liver after chemotherapy of acute leukemia: Report of two cases. Ann Intern Med 1976; 85:578-582.
12. Katzka DA, Saul Sh, Jorkasky D, et al. Azathioprine and hepatic venocclusive disease in renal transplant patients. Gastroenterology 1986; 90:446-454.
13. Vassal G, Hartmann O, Benhamou E. Busulfan and veno-occlusive disease of the liver [letter] Ann Intern Med 1990; 112:881.
14. Clark PA, Hsia YE, Huntsman RG. Toxic complications of treatment with 6 merpaptopurine: Two cases with hepatic necrosis and intestinal ulceration. Br Med J 1960; 1:393-395.
15. Weiss DL, De Los Santos R. Urethane-induced hepatic failure in man. Am J Med 1960; 28:476-481.
16. Reed GB, Cox AJ. The human liver after radiation injury: a form of veno-occlusive disease. Am J Pathol 1966; 48:597-611.
17. Cream JJ, Pole DS. The Effect of methotrexate and hydroxyrurea on neutrophil chemotaxis. Br J Dermatol 1980; 102:557-563.
18. Walsdorfer U, Christophers E, Schroder J. Methotrexate inhibits polymorphonuclear leukocyte chemotaxis in psoriasis. Br J Dermatol 1983; 108:451-456.